United Therapeutics Announces Additional $100 Million Share Repurchase Program

United Therapeutics Corporation UTHR today announced that its Board of Directors authorized the repurchase of up to an additional $100 million of the company's common stock. This program will become effective on July 31, 2012, and will remain open for up to one year. Purchases may be made in the open market or in privately negotiated transactions from time to time as determined by United Therapeutics' management and in accordance with the requirements of the U.S. Securities and Exchange Commission. The company also announced that it had recently completed its previously-announced $300 million repurchase program by purchasing 2,045,192 shares of common stock for $88 million during the second quarter of 2012.